Clinicopathologic characteristics and diagnostic methods of RET rearrangement in Chinese non-small cell lung cancer patients

BACKGROUND: Rearranged during transfection (RET) rearrangement has been identified as one of the crucial oncogenic drivers in non-small cell lung cancer (NSCLC). Recently, two highly selective RET inhibitors have been approved by the US Food and Drug Administration and demonstrated remarkable respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Junnan, Li, Yan, Wei, Bing, Guo, Lei, Li, Weihua, Xia, Qingxin, Zhao, Chengzhi, Zheng, Jiawen, Zhao, Jiuzhou, Sun, Rui, Guo, Yongjun, Brcic, Luka, Hakozaki, Taiki, Ying, Jianming, Ma, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073740/
https://www.ncbi.nlm.nih.gov/pubmed/35529790
http://dx.doi.org/10.21037/tlcr-22-202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073740/
https://www.ncbi.nlm.nih.gov/pubmed/35529790
http://dx.doi.org/10.21037/tlcr-22-202

Ejemplares similares